Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Telix Pharmaceuticals Limited due to allegations of misleading statements and failure to disclose critical information regarding its prostate cancer therapeutic candidates, leading to significant investor losses [3][4][5]. Group 1: Allegations and Legal Actions - The complaint alleges that Telix and its executives materially overstated the progress of their prostate cancer therapeutic candidates and the quality of their supply chain, resulting in misleading statements about the company's business and prospects [3]. - On July 22, 2025, Telix disclosed receiving a subpoena from the U.S. Securities and Exchange Commission, which caused the price of Telix's American Depositary Shares to drop by over 13% in two trading sessions [4]. - Following the disclosure of a Complete Response Letter from the FDA on August 28, 2025, regarding deficiencies in the Chemistry, Manufacturing, and Controls package for TLX250-CDx, Telix's ADS price fell by more than 21% over two trading sessions [5]. Group 2: Class Action Details - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against Telix is January 9, 2026, with the lead plaintiff being the investor with the largest financial interest who is typical of class members [6]. - Faruqi & Faruqi encourages anyone with information regarding Telix's conduct, including whistleblowers and former employees, to contact the firm [6].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit for purchasers of Fluor Corporation securities during the specified Class Period, highlighting the importance of the lead plaintiff deadline on November 14, 2025 [1]. Group 1: Class Action Details - Investors who purchased Fluor securities between February 18, 2025, and July 31, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline to represent other class members [3][6]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, noting its history of successful settlements and recognition in the field [4]. - The firm has achieved significant recoveries for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Specifics - The lawsuit alleges that Fluor Corporation made false and misleading statements regarding project costs and financial guidance, which were impacted by subcontractor errors, price increases, and economic uncertainty [5]. - It is claimed that these misstatements led to a significant negative impact on Fluor's business and financial results, resulting in damages for investors when the truth was revealed [5].

Market Overview - U.S. stocks experienced a decline, with the Nasdaq Composite falling over 1% on Thursday, while the Dow decreased by 0.64% to 45,824.16 and the S&P 500 dropped 1% to 6,571.28 [1] - Energy shares increased by 0.5%, while health care stocks fell by 1.4% on the same day [1] Company Performance - Accenture (NYSE: ACN) reported better-than-expected fourth-quarter 2025 results, with earnings of $3.03 per share, surpassing the analyst consensus estimate of $2.96, and sales of $17.60 billion, slightly exceeding the estimate of $17.36 billion [2] Commodity Market - Oil prices decreased by 0.2% to $64.88, while gold also fell by 0.2% to $3,761.50. Silver prices rose by 1.2% to $44.725, and copper prices dropped by 1% to $4.7660 [5] European Market - European shares were lower, with the eurozone's STOXX 600 falling by 0.52%, Spain's IBEX 35 Index down by 0.18%, London's FTSE 100 down by 0.24%, Germany's DAX 40 dipping by 0.62%, and France's CAC 40 falling by 0.46% [6] Asian Market - Asian markets closed mostly lower, with Japan's Nikkei 225 gaining 0.27%, while Hong Kong's Hang Seng declined by 0.13%, China's Shanghai Composite fell by 0.01%, and India's BSE Sensex decreased by 0.68% [7] Notable Stock Movements - PepGen Inc. (NASDAQ: PEPG) shares surged by 89% to $5.03 following the announcement of a $100 million public offering at $3.20 per share [8] - SciSparc Ltd. (NASDAQ: SPRC) shares increased by 101% to $7.71 after announcing a quantum computing-enabled 3D protein modeling initiative [8] - Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose by 30% to $0.5264 after securing a national coverage agreement with UnitedHealthcare [8] - Stitch Fix, Inc. (NASDAQ: SFIX) shares dropped by 14% to $4.88 after releasing fourth-quarter results [8] - CarMax, Inc. (NYSE: KMX) shares fell by 23% to $43.86 after reporting second-quarter EPS and sales below estimates [8] - Cemtrex, Inc. (NASDAQ: CETX) shares decreased by 31% to $0.4359 following a 1-for-15 reverse stock split approval [8] Economic Indicators - U.S. wholesale inventories declined by 0.2% month-over-month to $898.8 billion in August, contrary to market expectations of a 0.1% increase [11] - U.S. durable goods orders rose by 2.9% month-over-month to $312.1 billion in August, compared to a revised 2.7% decline in July [11] - The U.S. trade deficit in goods decreased by $17.3 billion month-over-month to $85.5 billion in August, better than market estimates [11] - Initial jobless claims fell by 14,000 to 218,000 in the third week of September, below market expectations [11] - The U.S. economy grew at an annualized rate of 3.8% in the second quarter, an increase from the previous estimate of 3.3% [11]